Transaction Search Form: please type in any of the fields below.
Date: April 29, 2024 Mon
Time: 8:38 pm
Time: 8:38 pm
Results for fake drugs
1 results foundAuthor: Bate, Roger Title: The Deadly World of Fake Drugs Summary: The burden of fake and substandard drugs is not evenly distributed across the globe. Even where reporting systems are weak and the media is not free, most reported instances of substandard medicines occur in poorer countries, where poor regulation allows criminals to easily infiltrate weak supply chains. Although rich nations face fewer breakdowns in their regulation and supply systems, they are certainly not safe from this threat. This document provides a plethora of examples of the manufacture, sale, and distribution of fake and substandard drug examples from all over the world. Where possible, data has been summarized to report problems at the continental, regional and national levels. Although no comprehensive data on the magnitude of the counterfeit drug trade exists, this document illustrates the breadth, depth, and danger of the problem globally. Many of these examples were compiled from local news sources. Countries without a free press may not appear at all in the following pages, but it is doubtful that the lack of evidence reflects an inconsequential number of substandard drugs. It is much more likely that these locations have a major problem with counterfeit and substandard drugs but data for these locations are simply unavailable. Evidence we do have suggests that counterfeit products are as much a problem in locations without a free press as they are elsewhere. In fact, in some countries like North Korea, counterfeiting operations are part of a vast, government-sponsored enterprise. Some stories of major counterfeiting rings involve numerous countries. Since the reader may only be interested in a specific countries, key statistics from the study are quoted in each location they pertain to, resulting in some overlap. Finally, because of the nature of the literally hundreds of sources cited in this section, it is inevitable that there will be a confusion of definitions. What one reporter, government agency, police statement, pharmaceutical company, academic researcher and others may call a fake product, their peers may not. For this reason, the reports in this chapter should not be viewed as necessarily comparable. In some instances it is possible to tell the claims made apart but overall it is not, and therefore is rarely attempted. With this major caveat in mind, this document hopefully provides a useful detail of the widespread and dangerous nature of dangerous medicines. Details: Washington, DC: American Enterprise Institute, 2012. 145p. Source: Internet Resource: Accessed July 11, 2012 at: http://www.aei.org/files/2012/02/27/-appendix-a-master-2_170026856632.pdf Year: 2012 Country: International URL: http://www.aei.org/files/2012/02/27/-appendix-a-master-2_170026856632.pdf Shelf Number: 125547 Keywords: Counterfeit MedicinesFake DrugsPrescription Drugs |